Table 2 Clinical characteristics of the CRC subgroup of 52 patients

Age – mean years (95% CI)

55 (51–59)

Gender – Male/Female

21/31

IPC administered

37

   SPIC

7

   HIPEC

30

    Oxaliplatin

12

    Oxaliplatin + irinotecan

18

PCI – mean (95% CI)

21 (18–24)

CC score

   0

27

   1

5

   2

4

   3

16

Diagnosis

   Colon

47

   Rectum

5

Preoperative chemo

39

   Oxaliplatin/5-FU ± bev

30

   Oxaliplatin/5-FU + cet

1

   Oxaliplatin/capecitabine ± bev

4

   Irinotecan/5-FU + bev

1

   Capecitabine

1

   5-FU alone

2

Adjuvant systemic chemo

15

   Oxaliplatin/5-FU ± bev

8

   Irinotecan/5-FU ± bev

2

   Capecitabine

1

   5-FU alone

1

   Missing data on drug

3